Copy
View this email in your browser

'Convergence of Public Health and Precision Oncology into Precision Public Health'


Management of breast and prostate cancer comprises a large proportion of the work of clinical cancer genetics and oncology services, but translation of findings from basic science into clinical and public health usage remains largely unfulfilled. Genomics (and epigenomics) is one of many factors that can advance precision medicine, but principles of public health remain important to guide the foundation of this work. 

Presented by

Professor Melissa C. Southey OAM, BSc (Hons, Pathology) PhD (Medicine), GradDip (Law), is a Molecular Geneticist (FHGSA) and a Founding Fellow of the Faculty of Science, Royal College of Pathologists of Australasia (FFSc, RCPA). She is Chair of Precision Medicine, School of Clinical Sciences at Monash Health, Director of Monash University’s new Biobanking Victoria initiative and Research Director of the Monash Partners Comprehensive Cancer Consortium.

Friday 25 June 2021
1pm to 2pm


Click here to join

https://monash.zoom.us/j/81598220419?pwd=N3phdTEva1dWQnBxbVpMeXdaT3J6Zz09

Register for this seminar
Monash Partners Comprehensive Cancer Consortium (MPCCC) is a strategic alliance of health service and research organisations working in partnership to improve cancer outcomes through integrated, collaborative and innovative research, service improvement and clinical care programs. Our partner organisations include Monash University, Hudson Institute of Medical Research, Alfred Health, Monash Health, Peninsula Health, Cabrini Health and Eastern Health.
Twitter
Website
LinkedIn
Copyright © 2021 MPCCC, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp